NaviMedix
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NaviMedix - overview
Established
1998
Location
Boston, MA, US
Primary Industry
Healthcare IT
About
NaviMedix is a healthcare technology company that offers innovative communication and collaboration solutions to improve patient care and streamline interactions between healthcare providers and payers. Founded in 1998, NaviMedix is based in Boston, US. The company specializes in healthcare communication solutions. In January 2016, NantWorks and its subsidiary NantHealth acquired NaviNet, the parent company of NaviMedix.
The most recent funding round occurred in January 2016, where the company raised USD 27. 00 mn in SERIES C funding led by North Bridge Venture Partners, along with participation from Atlas Venture, Coral Group, GE Capital Equity, Highmark Blue Cross Blue Shield, and Internet Healthcare Group. The total amount raised by the company stands at USD 27. 00 mn, with three deals recorded to date.
NaviNet, Inc. offers a comprehensive suite of healthcare communication and collaboration solutions designed to enhance the efficiency of patient care and streamline interactions between healthcare providers and payers. The company's core product offerings include NaviNet Open, a platform that facilitates real-time communication and data exchange among healthcare professionals, enabling them to manage patient information effectively and coordinate care seamlessly. These services aim to resolve critical challenges in the healthcare ecosystem, such as reducing administrative burdens and improving patient outcomes.
NaviNet serves a diverse client base, including hospitals, physician practices, and health plans across various geographical markets, including the United States and select regions in Canada. The end users of these services are primarily healthcare providers and patients who benefit from improved access to information and better care coordination. NaviNet generates revenue through a subscription-based model that allows healthcare organizations to access its suite of services. Clients typically engage in long-term partnerships, where they pay regular fees for continued access to the NaviNet platform, facilitating ongoing communication and data services.
Revenue is derived from various service tiers tailored to the specific needs of different healthcare providers, including larger hospital systems and smaller practices. The flagship service, NaviNet Open, is central to these transactions, providing essential functionalities that enhance collaboration among users. By leveraging a structured pricing approach, NaviNet offers scalable solutions that cater to the financial capacities of its diverse client base, ensuring that healthcare organizations of all sizes can improve their operational efficiency and patient care delivery. As of now, NaviMedix has not publicly announced any upcoming products or specific plans for expanding into new markets.
However, the recent funding of USD 27. 00 mn will likely be utilized to enhance existing services and potentially explore new market opportunities. Following the acquisition by NantWorks and NantHealth, the company may also leverage synergies from its parent company to drive growth and innovation in healthcare communication solutions.
Primary Industry
Healthcare IT
Sub Industries
Public Relations & Communications, Healthcare IT
Website
www.navinet.net
Company Stage
Acquired
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.